Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Altamira Therapeutics Ltd. (CYTO)

  • Technical Exchange News
  • Dec. 20, 2024, 00:51 UTC
  • 41
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Altamira Therapeutics Ltd. - Common Shares.

Comment Full text

Altamira Therapeutics Ltd. (CYTO)

  • Technical Exchange News
  • Dec. 20, 2024, 00:51 UTC
  • 41
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Altamira Therapeutics Ltd. - Common Shares. New value: Altamira Therapeutics Ltd. - Common Shares.

Comment Full text

Senti Biosciences Inc. (SNTI)

  • Technical Exchange News
  • Dec. 19, 2024, 21:45 UTC
  • 44
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Ekso Bionics Holdings Inc (EKSO)

  • Technical Exchange News
  • Dec. 19, 2024, 21:45 UTC
  • 46
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Altamira Therapeutics Ltd. (CYTO)

  • Technical Exchange News
  • Dec. 19, 2024, 21:44 UTC
  • 45
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Conduit Pharmaceuticals Inc (CDTTW)

  • Technical Exchange News
  • Dec. 19, 2024, 21:44 UTC
  • 45
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Citius Pharmaceuticals Inc. (CTXR)

  • Technical Exchange News
  • Dec. 19, 2024, 03:03 UTC
  • 46
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Briacell Therapeutics Corp (BCTXW)

  • Technical Exchange News
  • Dec. 19, 2024, 03:02 UTC
  • 43
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Aptevo Therapeutics Inc. (APVO)

  • Technical Exchange News
  • Dec. 19, 2024, 03:02 UTC
  • 45
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Citius Pharmaceuticals Inc. (CTXR)

  • Technical Exchange News
  • Dec. 18, 2024, 19:33 UTC
  • 46
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 289
  • 290
  • 291
  • 292
  • 293
  • Next

Search

News categories

  • Technical Exchange News(10898)
  • Event(2301)
  • SEC News(190188)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124812)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin